Connect with us

LSD

Blackhawk’s MindBio Therapeutics Enters its 80th and Final Patient into Phase 1 Clinical Trials and Provides Update for MindBio Spinout

 

MindBio is about to complete the world’s first clinical trial of its kind microdosing a psychedelic medicine to patients who are prescribed the drug…

Published

on

 

  • MindBio is about to complete the world's first clinical trial of its kind microdosing a psychedelic medicine to patients who are prescribed the drug to take at home 

  • Independent safety audit committee review successfully competed  

  • Two Phase 2 clinical trials to follow 

  • Proposed meeting date of shareholders to approve the spinout - June 20, 2022 

Vancouver, British Columbia - TheNewswire - April 04, 2022 - Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (OTC: BLRZF) (Frankfurt:0JJ) (the "Company" or "Blackhawk") is pleased to announce that MindBio Therapeutics Pty. Ltd. ("MindBio") has entered its 80th and final patient into its Phase 1 clinical trial microdosing LSD (Lysergic Acid Diethylamide) in the largest safety trial of its kind ever to have been completed.

The global depression drugs market reached a value of US $12.7 Billion in 2020.1  MindBio is targeting this market with the most promising innovation in treating depression that has occurred since the invention of traditional modern anti-depressant medications in the mid 1980s.

Despite the investment in these traditional anti-depressant medications and their prescription by doctors and psychiatrists all over the world, the mental health crisis and prevalence of depression and related mood disorders has escalated with one of the leading causes of death in young people, being suicide.2

MindBio has also started preparation work for two Phase 2 Clinical Trials including the design of psychedelic microdosing formulations that can subsequently be manufactured under Good Manufacturing Practices (GMP) standards for use both commercially and in Clinical Trials.

MindBio is working towards creating a safe and effective microdosing regimen using psychedelics that can ...

Full story available on Benzinga.com

Read More

Trending